|
|
|
|
Congressional Testimonies
- DoD admits physical protection is paramount and vaccines are not to be relied upon for primary protection.
- "...However, a preliminary review of the data available indicates there is insufficient information to support a licensure amendment because there is no correlation between protection in vaccinated non-human primates and antibody levels in vaccinated humans."
- "...waiving of the DOD
directed supplemental testing to meet developing contingency use requirements."
- "...reactions in over 600 individuals given three primary injections of our Anthrax Vaccine"
- "...I informed Dr. Myers (Fall 1996) that any extension of dating of product must first be reviewed and approved as a Supplement to the product license."
- LTC Randolf puts his spin on the news
- "...While the package insert for this vaccine is nonspecific as to the route of exposure, DoD has long interpreted the scope of the license to include inhalation exposure, including that which would occur in a biological warfare context."
- "...A concern, however, that must be addressed is the possibility that an adversary could develop, by genetic engineering or other means, an organism capable of circumventing the protective effect provided by this vaccine."
- "Prophylaxis and Therapy: All medical prophylactic modalities described should be viewed only as secondary (i.e., backup), and are not to be relied upon as primary protective measures."
- US Department of State anthrax vaccine policy
- Although FDA has approved only a three year shelf life, the DOD has plans for long-term, indefinite storage of vaccines
- Anthrax Vaccine Stockpile Analysis--Problems
- Anthrax Vaccine Stockpile Analysis--Worse Problems
|
|
|
|
|
|
